← Back to guidelines
Infectious Disease14 papers

Foreign body in heart

Last edited: 4/15/2026

Overview

Intracardiac foreign bodies, particularly metallic ones, pose significant clinical challenges due to their potential for causing arrhythmias, mechanical obstruction, and systemic embolization. Management strategies remain debated, with ongoing research aimed at improving outcomes 1.

Diagnosis

  • Clinical Presentation: Symptoms may include chest pain, palpitations, dyspnea, or signs of systemic embolization 1.
  • Imaging: Echocardiography (transthoracic or transesophageal) is crucial for localization and assessment of the foreign body 1.
  • Electrocardiography: Useful for detecting arrhythmias or conduction abnormalities 1.
  • Cardiac Catheterization: May be necessary for definitive diagnosis and potential retrieval 1.
  • Management

  • Surgical Retrieval: Often considered first-line for definitive removal of metallic foreign bodies 1.
  • Endovascular Approaches: Catheter-based techniques can be adjunctive or primary, depending on accessibility and expertise 1.
  • Anticoagulation: Considered pre- and post-procedurally to prevent thromboembolic events, specific drug classes not detailed 1.
  • Antiarrhythmic Therapy: Initiated if arrhythmias are present, specific agents not specified 1.
  • Special Populations

  • Pregnancy: Management strategies are extrapolated from general guidelines due to limited specific data 1.
  • Pediatrics: Special considerations for size and developmental stage, tailored surgical and endovascular approaches recommended 1.
  • Elderly: Increased risk of comorbidities necessitates careful risk-benefit assessment for invasive procedures 1.
  • Comorbidities: Presence of conditions like renal impairment may influence choice of anticoagulants and procedural risks 1.
  • Key Recommendations

  • Surgical or endovascular retrieval should be considered based on the accessibility and expertise available (Evidence: Moderate 1).
  • Echocardiography is essential for initial diagnosis and guiding further management (Evidence: Strong 1).
  • Prophylactic and therapeutic anticoagulation should be tailored to individual patient risk (Evidence: Expert opinion 1).
  • References

    1 Wang X, Zhao X, Du D, Xiang X. Management of metallic foreign bodies in the heart. Journal of cardiac surgery 2012. link

    Original source

    1. [1]
      Management of metallic foreign bodies in the heart.Wang X, Zhao X, Du D, Xiang X Journal of cardiac surgery (2012)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG